| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.2M | +43.8% | -4.6% |
| SG&A Expense | $1.5M | +0.3% | +6.4% |
| Operating Income | -$2.6M | -15.9% | -1.2% |
| Interest Expense | $17K | +0.0% | -83.0% |
| Net Income | -$2.0M | +7.4% | +18.8% |
| EPS (Basic) | -$0.05 | +0.0% | +44.4% |
| EPS (Diluted) | -$0.05 | +0.0% | +44.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.0M | -12.7% | -39.7% |
| Current Assets | $9.3M | -12.0% | -39.8% |
| Total Assets | $9.4M | -12.0% | -40.5% |
| Total Liabilities | $1.5M | +54.1% | +69.1% |
| Stockholders' Equity | $7.9M | -18.5% | -47.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | -103.2% | — |
| Financing Cash Flow | $15.0M | — | — |